The Clinical Analysis of Non-dialysis End-stage Chronic Kidney Disease Accepting Percutaneous Coronary Intervention

HAN Xiao-ning,DING Wen-hui,GONG Yan-jun,CHU Song-yun,LIU Lin,SHI Li-bin
DOI: https://doi.org/10.13241/j.cnki.pmb.2013.06.017
2013-01-01
Abstract:Objective: To investigate the non-dialysis end-stage kidney disease patients underwent percutaneous coronary inter-vention(PCI) treatment of the clinical features and treatment outcomes.Methods: The clinical data of seven patients who diagnosed and treated with PCI for coronary heart disease in non-dialysis end-stage kidney disease were retrospectively analyzed.The analysis focused on the occurrence and outcome of contrast induced nephropathy(CIN).Results: All patients with severe multivessel lesions except one,of which interventional treatment underwent only in part of the stenosis.All patients post PCI without regular dialysis showed more than 44.2 μmol / L increasing for creatinine.5 patients required dialysis,of which there are three cases discharged still cannot be separated from the dialysis.Before discharge,serum creatinine of all patients separated from the dialysis declined to the level before the interven-tion.All the patients took dual antiplatelet drugs and accepted the low molecular weight heparin subcutaneous injection without serious bleeding events.Seven patients were discharged in stable condition.Conclusion: In the end-stage non-dialysis kidney disease patients with percutaneous coronary intervention,CIN rate is close to 100%.These patients still have a protective effect from hydration,isotonic contrast agent,and the adoption of prophylactic dialysis.Renal function prior to the intervention is to determine whether patients need the most important factor of long-term dialysis.The higher the contrast agent ratio,the smaller the possibility of from the dialysis post PCI.
What problem does this paper attempt to address?